Inspection Record

Isologic Innovative Radiopharmaceuticals of Ontario Limited — Health Canada Inspection Findings

Health CanadaInspected 2023-08-21 6 findingsAseptic processing and sterility assuranceDeviation, CAPA, and investigationOther quality system

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

The company's cleaning of the premises and the equipment in aseptic areas was inadequate.

2Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

3Aseptic processing and sterility assurance

The validation of aseptic processing was inadequate.

4Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

5Other quality system

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

6Other quality system

The controls put in place for electronic signatures were inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-08-21. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Isologic Innovative Radiopharmaceuticals of Ontario Limited company profile — full history Health Canada documents, 2023 Go to Findings search